Concepedia

Joseph A. Fraietta

JA

Statistics

Publications

78

Citations

14.5K

H-Index

42

Active since

2010

Affiliations

University of Pennsylvania(Current)

Parker Institute for Cancer Immunotherapy

Children's Hospital of Philadelphia

Novartis (United States)

Translational Therapeutics (United States)

Joseph A. Fraietta is an author at University of Pennsylvania specializing in immunology, life sciences, and immunotherapy.

ORCID

Publications per year

2010–2025

78

Publications

78

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando et al. · Nature Medicine · 2018 · 1.8K citations · Full text

, , +16

CRISPR-engineered T cells in patients with refractory cancer

Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis et al. · Science · 2020 · 1.4K citations · Full text

, , +17

Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells

Omkar U. Kawalekar, Roddy S. O’Connor, Joseph A. Fraietta et al. · Immunity · 2016 · 1.2K citations · Full text

, , +17

Decade-long leukaemia remissions with persistence of CD4+ CAR T cells

J. Joseph Melenhorst, Gregory M. Chen, Meng Wang et al. · Nature · 2022 · 920 citations · Full text

, , +14

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

Joseph A. Fraietta, Christopher L. Nobles, Morgan A. Sammons et al. · Nature · 2018 · 861 citations · Full text

, , +14

1–5 of 78